chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Slight sore throat; Running nose; Sweating; Body aches; Viral flu-like symptoms; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (Slight sore throat), RHINORRHOEA (Running nose), HYPERHIDROSIS (Sweating), PAIN (Body aches) and INFLUENZA LIKE ILLNESS (Viral flu-like symptoms) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025B21A) for COVID-19 vaccination.     Concurrent medical conditions included Tonsillitis, Infection, Flu-like symptoms, Allergy and Diabetes. Concomitant products included PAROXETINE HCL for Anxiety, GLIPIZIDE, METFORMIN HCL and BENAZEPRIL HCL for Diabetes, PRAVASTATIN, METOPROLOL SUCCINATE, LORATADINE, PSEUDOEPHEDRINE SULFATE (CLARITIN D 12 HOUR) and MULTIVITAMIN FOR WOMEN for an unknown indication.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Apr-2021, the patient experienced OROPHARYNGEAL PAIN (Slight sore throat), RHINORRHOEA (Running nose), HYPERHIDROSIS (Sweating), PAIN (Body aches) and INFLUENZA LIKE ILLNESS (Viral flu-like symptoms). The patient was treated with DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PARACETAMOL, PSEUDOEPHEDRINE HYDROCHLORIDE (DAYQUIL) for Symptomatic treatment, at an unspecified dose and frequency and IBUPROFEN for Symptomatic treatment, at an unspecified dose and frequency. On 26-Apr-2021, HYPERHIDROSIS (Sweating), PAIN (Body aches) and INFLUENZA LIKE ILLNESS (Viral flu-like symptoms) had resolved. At the time of the report, OROPHARYNGEAL PAIN (Slight sore throat) and RHINORRHOEA (Running nose) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment medications also included Claritin D.
pt recv vax 23JUN94 & on 1AUG95 pt broke out in bumps & hives;pt reported that many people @ work place devel hives when all vaccinated (WAES96011518);
104F fever; Vomiting; Aches; Chills; This is a spontaneous report from a contactable consumer. A 41-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: ER8737), via an unspecified route, administered in Left Arm on 14Apr2021 at 14:30 (at the age of 41-years) as single dose for COVID-19 immunization. The patient's medical history included allergy to cephalosporins and chronic hives of unknown origin. The patient had no other known allergies. The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. The patient's concomitant medication(s) included cetirizine and methylphenidate. The patient previously received first dose of BNT162B2 (Lot Number: ER8727), via an unspecified route of administration on 24Mar2021 at 19:15 (at the age of 14-years) as single dose for COVID-19 immunization. Prior to vaccination, the patient was not diagnosed with COVID-19. On 15Apr2021 at 16:00, the patient experienced 104F fever, vomiting, aches, chills. The patient did not receive any treatment for the events. The patient underwent lab tests and procedures which included body temperature: 104F fever. Since the vaccination, the patient had not been tested for COVID-19. The outcome of the events was resolved in Apr 2021.  No follow-up attempts are needed. No further information was expected.
Arm itches; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Arm itches) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (Arm itches). At the time of the report, VACCINATION SITE PRURITUS (Arm itches) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications was not provided. Treatment information was not provided.
Hives all over body and swollen left arm 3 days after H1N1 vaccine was given.
Received second Pfizer covid vaccine dose on 11/3/2021. The first dose was on 10/18/2021. The second shot should have been given the earliest on 11/4/2021. Noticed after the shot was given that it was early.
Expired Product Used; Expired Product Used; This case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 16-year-old female patient who received Men B NVS (Bexsero) (batch number ABXA95AA, expiry date 28th February 2022) for prophylaxis.   Co-suspect products included meningococcal B recom vaccine + aloh + omv pre-filled syringe device (Bexsero Pre-Filled Syringe Device) injection syringe for prophylaxis, Men B NVS (Bexsero) (batch number ABXA95AA, expiry date 28th February 2022) for prophylaxis and meningococcal B recom vaccine + aloh + omv pre-filled syringe device (Bexsero Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 1st April 2022, the patient received the 2nd dose of Bexsero and Bexsero Pre-Filled Syringe Device. On 1st March 2022, the patient received the 1st dose of Bexsero and Bexsero Pre-Filled Syringe Device. On 1st March 2022, not applicable after receiving Bexsero and Bexsero Pre-Filled Syringe Device and unknown after receiving Bexsero and Bexsero Pre-Filled Syringe Device, the patient experienced expired vaccine used. On 1st April 2022, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used and expired vaccine used were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 06-Apr-2022 Reporter's Comments: The patient was administered 1st and 2nd dose of Bexsero, both the dosed were expired. At the time of reporting, repeat dosing had not been performed. The vaccine administration facility was the same as primary reporter. The reporter consented to follow up. Additional Supportive Information: The patient received 1st and 2nd dose of Bexsero, which were expired on 28th February 2022, which led to expired vaccine used and expired vaccine used.
He got the vaccine, he went home and 3-4 days later he was getting severe chills, which he felt was weird.  The temp in the house was about 73, but he was freezing, and turned the heat up.  Then that kind of went away and then maybe a week later to 10 days that feeling came back.  He then started taking Ibuprofen and Advil and then was getting hot, and off and on with the chills.  Once the medication wore off he would get the chills again.  He did get a COVID test which was negative about 2 weeks after.  He then noticed that while he was sick he started having nausea and was vomiting, and then started having ringing in his ears, kind of like something released in his ear canal, pressure release sound and then the ringing in the ear which has not gone away still, 9/8/21.   He has seen an ENT for the tinnitus, who said that it could be caused from the vaccine and gave him some information, and informed him that other people have had this as well.  He also mentioned cochlear hydrops or reaction to the vaccine and gave him some information.  He did not prescribe any medication, Dr.  who said there was  nothing to give him.   He last saw him on August 2.    He also saw another provider, , ENT also who wanted him to do an MRI and he has already spent over $1000.00 to $1500.00 and got a 2nd opinion, and Dr.  told him to lower his salt intake and has been doing remedies that does not seem to be improving the condition.    He has been really depressed and borderline suicidal dealing with this condition.
We did not administer the vaccine.  The pt was admitted to our hospital on 4/18 with ITP, platelets of 3k.
Employee developed a headache at 2:33pm. Donor stated she then had two episodes of emesis at 4:20pm after leaving the center. Employee stated she felt better after second episode of emesis and has tolerated oral fluids without any further nausea or vomiting. Employee also stated her headache has subsided as well.
MODERNA VACCINATION REACTION; Dizziness; COVID-19; This spontaneous case was reported by a consumer and describes the occurrence of IMMUNISATION REACTION (MODERNA VACCINATION REACTION), DIZZINESS (Dizziness) and COVID-19 (COVID-19) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Crohn's disease.    No Medical History information was reported.   On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form and ADALIMUMAB (HUMIRA) (Subcutaneous) CF. On an unknown date, the patient experienced IMMUNISATION REACTION (MODERNA VACCINATION REACTION), DIZZINESS (Dizziness) and COVID-19 (COVID-19). At the time of the report, IMMUNISATION REACTION (MODERNA VACCINATION REACTION) and DIZZINESS (Dizziness) outcome was unknown and COVID-19 (COVID-19) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Formulation of Humira was reported as Solution for injection in pre-filled pen.  No concomitant medication was reported.   No treatment information was provided.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
Pt c/o Right chest tightness, and phlegm in her throat, coughing. Her VS (BP/HR, SBP @ 140-170'a) VS stable all throughout, sat 100% the whole time. Called Dr., ordered to give Benadryl 25 mg po and Albuterol 2 puffs inhaler. Her symptoms got better, but continued. Called 911 since she's still coughing and continue to have the 'phleghm' like symptoms in her throat.' 911 assessed her and pt refused to go to ER for further treatment, she signed the paper. Sent her home with her husband, and instructed her to call 911 if her symptoms get worst.
pt recv vax & did not sleep for 36hr p/vax;pt did not cry;pt then slept for 72hr;pt mom notified the MD of this event on 20MAY97
Head ache and body aches as expected. But also a hard red patch about 5 inches below injection site; my lips got swollen as if I had worn a 'bad' cosmetic; eyes were slightly swollen and watery; had some colitis reaction too. Also joint pain and tender abdomen. Just seems like a lot of inflammation.
11 days after vaccination patient had the onset of generalized myalgias, headaches. This was followed by the onset of unilateral facial weakness 17 days after vaccination. On examination, he had ataxia and facial weakness.  He had MRI's, LP and EMG/NCS which confirmed demyelinating polyradiculoneuropathy, presumably Miller Fisher variant of Guillain Barre Syndrome.
A 17-year-old male patient received the first dose of TRUMENBA via an unspecified route of administration on an unspecified date at 0.5 ml single for immunization. The patient medical history was not reported. Concomitant medication included HPV vaccine. The patient received meningococcal group b rlp2086 and HPV vaccine in the same arm. The patient experienced burning and pain at the injection site on an unspecified date. The outcome of event was unknown. The patient experienced burning and pain at the injection site on an unspecified date. The outcome of event was unknown. Amendment: This follow-up report is being submitted to updated information on concomitant vaccine for a correct electronic transmission to health authorities.
Sore at injection site; All over body aches; Slight fever; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EWO164) via an unspecified route of administration in the right arm on 19Apr2021 at 14:30 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included atorvastatin (MANUFACTURER UNKNOWN), taken for an unspecified indication from an unknown date and unknown if ongoing. The patient previously received ibuprofen; diphenhydramine citrate (ADVIL PM) and experienced drug allergy with the blue dye present in it; glutamate sodium (MONOSODIUM GLUTAMATE) and also experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the right arm on 27Mar2021 at 11:00 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. On 19Apr2021 at 16:00, the patient experienced sore at injection site, all over body aches, slight fever and fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sore at injection site, all over body aches, slight fever and fatigue was resolved on an unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
2 inch purplish red center with 2 inch reddened area around this. Customers states area itches and has no pain. No fevers or warm to the touch
approximately 4 days following my first injection, I began having what appears to be breakouts of what look like hives, globally around my body. Spoke with my Dr, who spoke with infection control specialist who said get second shot and I was to take Claritin. Continued having  global break following second shot,  some causing large hard lumps on buttocks, face, arms and neck. Referred to Allergy and test run. Told to take Zyrtec for 30 days.
Angioedema/rash on neck, face, and abdomen, chills, fever, SOB, hyperacusis, tinnitus
Patient received the vaccine and went to sit down in the chair. Patient stated she started feeling nauseous and light headed so asked if she can wait outside for some fresh air. When she went outside, she sat on the edge of the stairs and fell backwards and passed out. The store manager was there to catch her before her head hit the pavement. Patient wasn't alert for about 2 minutes. Pharmacist came out and assessed the patient and she was communicative. She was in and out but was able to tell us her name, DOB and where she was. We sat her up,  gave her some water, and waited with her. She requested not to call the ambulance. I checked her pulse at 1:15pm and it was 92. I checked her pulse again at 1:30pm and it went down to 72. Patient was fully alert and speaking in full sentences by 1:35pm. She called her mom and was able to stand up without feeling dizzy. She walked to the car with assistance and was driven home by her mother.
Around 5:30 PM, I had to stop putting up groceries, get into lounging clothes, and put a box fan on me while lying down.  I experience shortness of breath, rapid heartbeat, dizziness, and weakness.  My left upper quadrant is sore from the  Moderna vaccine.  It appears to be spreading circular to the size of a quarter to about the size of a fifty-cent piece.  I had gone to sleep.  I contacted the veteran 24 hour nurse, my best friend, and my brother to tell them my health status.  I had eaten dinner, taken a Tylenol, and went back to sleep before brushing my teeth.
On Tues 05/18/2009 pt told mom left upper arm hurts.  Mom noticed left arm red, swollen warm to touch.  Mom called Dr, she told mom to put heat on arm.  Mom called Wed, saw child in office gave her 1000 mg ot RECEPHIN IM (500 in each thigh).
Woke up around 4:30 am on 8/20/21 in extreme pain in the left rear flank area. Called my healthcare provider and was advised to go to emergency room at contracted hospital. After hanging up from speaking to the doctor, I vomited clear liquid. I had not had anything to eat or drink since around 8:00 pm the night before. Was checked in to the ER by 7:00 am, and had to stay in a plastic chair in waiting room in intense pain, vomiting clear liquid and in intense pain. By 9:30 am I was no longer in pain, and when I was seen again around 12:00 pm for a second vitals check the Triage nurse had a doctor see me right away so I could be released as she had thought I had a kidney stone. The doctor spoke to me on 3 or 4 different occasions, prescribed meds, and while I was waiting to pick them up at the pharmacy, I passed the kidney stone in the bathroom. I was not given a screen to urinate in.
Lightheadedness after administration of the HPV vaccine. Patient was pale, dizzy, nauseated. BP, HR stable lying, sitting. Unable to stand due to dizziness. After lying down x 10 minutes, patient able to get up and leave office unassisted. No loss of consciousness.
5 days after injection woke up with severe vertig. Dizziness, night sweats, low blood pressure lated for a week. Still feeling occasional dizziness 4 weeks after first shot
-Arm numbness, dizziness -Seen by on-site EMT in medical screening. Patient did not eat prior to vaccine. BP:133/94 HR:89 PO2:100% RA Patient release at 12:06 p.m.
The day of the shot I got tingling in the bottom of both feet.  Sixteen days after the shot I started to feel tingling down my back left side.
Pt recv vax on 5/18/98; on 5/19/98 pt exp no appetite, weak, nausea, tired, aches in shoulders; pt imp 5/26/98
A male patient with no known medical history had received a subcutaneous injection of YF-VAX (batch number UE951AA) on 04 May 2007 and 5 days later, on 09 May 2007, experienced pain, redness, and a hard nodule at the injection site. Additional vaccinations received on 04 May 2007 included oral Typhoid (Berna, batch number 3001160) and Hepatitis A (Merck, batch number not provided). The patient had received one prior dose of Hepatitis A vaccine, and no prior doses of YF-VAX or oral Typhoid. He was not suffering from any illnesses at the time of vaccination. The events had not yet recovered. The reporter stated that the patient's father had received the same vaccinations, and developed the same adverse events; the father's information is captured in case number 2007-01744. This case pertains to the son.
pt had dime sized area of inflammation immed p/vax; had hx of flu shot 1yr ago w/o problems;pt c/o SOB;vital signs remained stable;pt was briefly examined by MD;
headaches; fever; chills; muscle pain; This is a spontaneous report from a Pfizer-sponsored program. A contactable female consumer reported about herself. A female patient of an unspecified age received first dose of bnt162b2 (BNT162B2; Solution for injection, Lot number: UNKNOWN), via an unspecified route of administration as dose 1, single on 21Feb2021 for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. Patient received the first dose last Sunday on 21Feb2021 and asked if it was possible to experience side effects in 3 days. Patient experienced headaches, fever, chills, and muscle pain after the first dose on unspecified date in Feb2021. Patient was not sure if this was from the vaccine or not since this was not normal for her. At the time of this report, outcome of the events was unknown.  Information on the lot/batch number has been requested.  Follow-up attempts completed. No further information expected.
fully vaccinated 75-year-old male with past medical history significant for HTN, HLD, obesity, tobacco use, and prior DVTs admitted to Hospital on 07/27/2021 for shortness of breath. Patient was seen at urgent care on 07/25/2021 and found to be COVID-19 positive. CT angiogram performed to assess for pulmonary embolism. Imaging was equivocal but demonstrated bilateral patchy ground-glass opacities suggestive of bilateral pneumonia. Patient was administered and completed azithromycin, ceftriaxone, dexamethasone. Initially on 6L of oxygen by nasal cannula on admission. During his admission, patient's respiratory status worsened and he was placed on humidified high-flow nasal cannula at 60 L and 100% O2. Despite being on high-flow nasal cannula patient desaturated to the 70s and a rapid response was called. Patient was placed on BiPAP with some improvement in his respiratory status and was admitted to the hospital on 08/01/2021. On 8/7, his respiratory status progressively worsened and he was sedated and intubated. On 8/8, code status was changed to DNR. He developed progressively worsening renal failure and increased vasopressor requirements to maintain his blood pressure. 08/01 Rapid response called for patient desaturating in the 70s while on 60L. Transferred to Hospital. 8/07 Intubated and sedated due to worsening respiratory failure. 08/08 Worsening hypoxemia, renal failure, Code status changed to DNR. 08/10 Family elects palliative extubation, withdrawal of care with comfort measures. On 8/10/21 following adequate time to say their goodbyes. Palliative extubation performed by RT at 1823 with Nurse and family at bedside. Loss of palpable pulses appreciated by Nurse.
Pt started feeling an upset stomach the morning after the vaccines (9/8 ~10AM) this then progressed to sharp pains in the chest and back in the evening towards the next morning (9/9). pt stated it hurt when he breathed in so he went to the ER on 9/9 at 3:30 PM and had a full workup to evaluate heart conditions, EKG, checked his a-fib, looked at arteries and everything came back fine. Was told to call the pharmacy to evaluate the possibility of the vaccines since nothing else made sense.
During administration the patients providing nurse, reported that the syringe leaked from the barrel and estimated the patient received approximately 50% or less of the dose.  After consulting with other clinical team members it was decided that the best course of action was to consider the amount given a dose.  This was based on the fact that we had no way to identify the exact amount to be given to complete a full 0.5ml dose.    The manufacturer, Moderna,  was then contacted for further guidance on the situation.  Moderna medical information stated that they have no current protocol regarding partial doses and that at this time receiving another dose or a dose in excess of the EUA recommended regimen has not been studied or recommended.
pt recv vax 21OCT97 & that same day pt exp an inj site rxn described as red, swollen, hot to touch from elbow to shoulder;
At 11:00 PM, 12 hours after the booster,, l became very nauseous and dizzy. I stood up to go to the restroom to vomit, and immediately collapsed and almost lost consciousness. Stuck on the floor, I began to feel intense shooting nerve pain in both of my arms, and broke out into an extremely intense sweat. I became hypersensitive to light, and felt like I was going to faint if I moved. I dialed emergency number. At the ER, I was treated with an anti-inflammatory injection, and with an injection of a migraine medication. I slowly began to feel better, and the next day had just a fever and fatigue.